US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new ...

Moderna's been anything but a high-flying growth stock in this investor's portfolio. So is it high time he gave up on this ...